#08 - Vaccine$ and Economic$: Prevention, Policy, & Pro$perity cover art

#08 - Vaccine$ and Economic$: Prevention, Policy, & Pro$perity

#08 - Vaccine$ and Economic$: Prevention, Policy, & Pro$perity

Listen for free

View show details

About this listen

 Episode framing Host Krishna frames vaccines as both medical and economic interventions, calling this discussion a "deep dive" into the economic ramifications of vaccination for public policy, health systems, insurers, employers, schools and GDP. Historical impact Edward Jenner's 1796 cowpox inoculation led to eventual smallpox eradication (WHO declared eradication in 1980). Smallpox eradication produced huge economic savings (U.S. estimate: >$1 billion/year saved by no longer vaccinating against smallpox; global savings much larger). Vaccination is characterized as "elimination of future liability," and Krishna asserts vaccines are the single most important driver of the roughly doubled human life expectancy over the past 150 years. Modern vaccine infrastructure and CDC modeling Childhood immunization programs prevent nearly 4 million deaths globally per year; about 42,000 deaths annually in a U.S. birth cohort and ~20 million hospitalizations over lifetimes. CDC modeling: routine childhood vaccination prevents $406 billion in societal costs and $76 billion in direct healthcare costs for a U.S. birth cohort. Return on investment: ~ $10 saved per $1 spent on childhood vaccines (near 1,000% ROI). Per-child economics: full immunization series costs ~$1,100–$1,500; direct healthcare savings per vaccinated child ~$7,000; societal savings ~$30,000. Actuarial effects & older adults Vaccination reduces expected claims liability, stabilizing premium growth. Medicare/elderly example: pneumonia and influenza hospitalizations average $12k–$20k per admission; ICU $30k–$50k; readmission rates 15–20%. Small percentage reductions in hospitalizations among seniors translate into hundreds of millions in annual savings and smooth actuarial "shock" spikes. Case studies of preventable illnesses Measles: pre-1963 had 3–4 million U.S. infections/year, 48k hospitalizations, 400–500 deaths. Vaccination cut cases ~99%. 2019 U.S. outbreak costs: $20k–$140k per case to public health departments (contact tracing, labs, isolation, staffing, school exclusions). MMR cost: ~$20–$25 per dose; two doses ≈97% protection — contrast tiny cost vs. large outbreak containment cost. Polio: pre-vaccine ~35,000 paralytic cases/year in U.S., lifelong disability, iron lungs. Lifetime cost for severe paralysis estimated $1–3 million per person; 10,000 cases would imply $10–30 billion in lifetime liabilities. Polio vaccine series in U.S. costs under $100; vaccine-derived polio re-emergence in under-vaccinated communities is alarming due to permanent paralysis and long-tail costs. Hepatitis B: infecting infants leads to ~90% chronicity without vaccination; chronic hepatitis B lifetime management costs $100k–$500k per patient; liver transplant ≈$800k+ first-year. Birth dose costs ≈$20. Vaccination avoids long-term specialist care, imaging, antivirals, cancer treatment and transplant costs — shifting liabilities away from Medicaid/Medicare. COVID-19: 2020 global GDP contracted ~3–4%; U.S. economy shrank ~$2.3 trillion. COVID vaccines prevented millions of hospitalizations and ~1 million deaths (U.S. figure cited), preserving workforce capacity and preventing trillions in productivity losses. Hidden costs of declining vaccination rates Direct: surges overwhelm hospitals (especially pediatric units), increase ICU utilization, skilled nursing transfers, and 30-day readmissions. Indirect: schools close or shift remote, causing learning loss; employers face more sick leave and absenteeism; insurers face higher claims leading to premium increases. Public health containment costs (contact tracing, overtime, lab testing) and uncounted societal losses (missed wages, long-term disability, educational setbacks) vastly exceed vaccine costs. Behavioral/market dynamics: "population memory" (generations without direct memory of severe disease undervalue vaccines), plus misinformation causes overweighing of rare adverse events and underweighing of invisible benefits, creating market failure and collective vulnerability (herd immunity erosion). Policy recommendations and interventions Strengthen school-entry vaccine requirements. Encourage insurance coverage mandates and involve insurers in promoting vaccination. Improve public education and outreach to vaccine-hesitant populations; admit past communication failures and emphasize empathetic engagement. Employer-based incentives, paid sick leave for brief vaccine side effects (24–48 hours), and workplace vaccination programs. Maintain or expand compensation programs for rare vaccine injuries to build trust. Protect and prioritize vaccine funding; cutting vaccine programs is likened to cancelling fire insurance to save money until disaster strikes. Ethical framing and conclusion Vaccination balances individual liberty with collective responsibility; vaccines protect vulnerable groups (infants, cancer/chemotherapy ...
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.